PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 8, 2020Cancer Cytopathology72 citationsOpen Access

ThyroSeq v3 for Bethesda III and IV: An institutional experience

View Full Paper
DDDimpi DesaiMLMarcos LepeZBZubair Baloch

Key Points

Key points are not available for this paper at this time.

Abstract

The high BCR of ThyroSeq v3 for AUS/FLUS prevents surgery in a majority of patients. The ThyroSeq v3 genomic classifier reveals the complexity of the genetic signature of indeterminate nodules.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Desai et al. (2020) studied this question.

synapsesocial.com/papers/69d89095e9c100a435ae2d8chttps://doi.org/10.1002/cncy.22362
Ask AI
Helpful
Bookmark
Share
View Full Paper